NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-1,033 Cr | ₹-477 Cr | ₹-5.30 Cr | ₹-103 Cr | ₹-167 Cr |
What is the latest Cash Flow from Investing Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-1,033 Cr |
Mar2023 | ₹-477 Cr |
Mar2022 | ₹-5.30 Cr |
Mar2021 | ₹-103 Cr |
Mar2020 | ₹-167 Cr |
How is Cash Flow from Investing Activities of NATCO PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,033 Cr | Negative | |
Mar2023 | ₹-477 Cr | Negative | |
Mar2022 | ₹-5.30 Cr | Negative | |
Mar2021 | ₹-103 Cr | Negative | |
Mar2020 | ₹-167 Cr | - |
Compare Cash Flow from Investing Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹18,535.1 Cr | 7.4% | 17.7% | -15.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 7.4% |
17.7% |
-15.5% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses